HSE banner

HM Nuclear Installations Inspectorate

GE HEALTHCARE LTD, MAYNARD CENTRE SITE, CARDIFF

QUARTERLY REPORT FOR 1 JANUARY – 31 MARCH 2006

Contents


Foreword

This report is issued as part of the Health and Safety Executive's commitment to make information about inspection and regulatory activities relating to the above site available to the public. It is for distribution to members of the Amersham plc Maynard Centre Local Liaison Committee (LLC) and covers activities associated with the regulation of safety at the site. These reports are distributed quarterly and are available also from the Internet at www.hse.gov.uk/nsd. Site Inspectors of HM Nuclear Installations Inspectorate attend LLC meetings and will be happy to respond to any questions raised there by members. Any other person wishing to enquire about matters covered by this report may contact HSE’s Nuclear Directorate Information Centre on 0151-951-4103.


Inspections

No NII inspections were made at the Maynard Centre this quarter.  (Inspections of relevance to the Maynard Centre were made at GE Healthcare Ltd’s nuclear licensed sites at Amersham (the Grove Centre) and Harwell; these are included below.  For instance, the sites have many arrangements in common for compliance with the conditions attached to their site licences.)


[back to top]

Routine matters

  Inspections are undertaken for the purpose of monitoring compliance with (i) the conditions attached by HSE to the nuclear site licences, and (ii) other relevant provisions of the Health and Safety at Work etc Act 1974, including the Ionising Radiations Regulations 1999.  In this period routine inspections included:

  1. Arrangements for the production and assessment of safety cases.
  2. Arrangements to control modifications to plants or processes.
  3. Arrangements for the preparation, review, and amendment of operating instructions.

Issues arising from these and previous inspections are being pursued.


[back to top]

Non-routine matters

Corporate

NuSAC:  In February, GE Healthcare Ltd gave a paper to the Health and Safety Commission’s Nuclear Safety Advisory Group.  The subject was safety lessons from the 2004 takeover of the licensee (then Amersham plc) by General Electric.  NuSAC noted the applicability of these lessons to the continuously changing scene nationally.

On 15 March Mike Weightman, HM Chief Inspector of Nuclear Installations, visited the headquarters of GE Healthcare to meet the licensee’s board and discuss events since the GE takeover.

Maynard Centre

Safety cases:  The second in a programme of safety cases for existing plants prepared to modern standards has been received.  It is for the main plants handling and storing radioactive waste.

No statutorily reportable incidents were notified to NII in this quarter.


[back to top]

Regulatory activity

As part of its regulation under the nuclear site licence NII issues formal regulatory documents, which include Consents, Approvals, Directions, and Licence Instruments(1).  In this quarter NII issued Licence Instrument No 503, agreeing to safety-related changes to the organisational structure of the licensee consequent on the replacement of the chairman and the director of safety.

No other issues have arisen that have required formal regulatory action.

(1) Licence Instruments are issued: to acknowledge receipt of specified documents, eg proposals for a new or modified plant; to stipulate whether the Inspectorate intends to examine these documents; or to agree to the start of a particular phase of construction, commissioning, modification, or decommissioning.